机译:Sofosbuvir和Leedipasvir与高持续的病毒学反应以及改善东亚乙型肝炎病毒感染的东亚患者与健康相关的生活质量有关
Center for Liver DiseasesInova Fairfax HospitalFalls Church Virginia;
Center for Outcomes Research in Liver DiseaseWashington District of Columbia;
Center for Outcomes Research in Liver DiseaseWashington District of Columbia;
Yonsei University College of MedicineSeoul Korea;
Yonsei University College of MedicineSeoul Korea;
Asan Medical CenterUniversity of Ulsan College of MedicineSeoul Korea;
Kaohsiung Medical University HospitalKaohsiung Medical UniversityKaohsiung Taiwan;
National Taiwan University College of Medicine and HospitalTaipei Taiwan;
National Hospital of Tropical DiseasesHanoi Vietnam;
Queen Mary HospitalThe University of Hong KongHong Kong China;
Institute of Digestive Diseasethe Chinese University of Hong KongHong Kong China;
Peking University People's HospitalBeijing China;
direct‐acting antivirals; health‐related quality of life; mental health; physical functioning; vitality;
机译:Sofosbuvir和Leedipasvir与高持续的病毒学反应以及改善东亚乙型肝炎病毒感染的东亚患者与健康相关的生活质量有关
机译:Sofosbuvir和Leedipasvir与高持续的病毒学反应以及改善东亚乙型肝炎病毒感染的东亚患者与健康相关的生活质量有关
机译:与丙型肝炎病毒(HCV)感染的东亚患者的健康有关的生活质量(HRQL):治疗和持续的病毒学反应(SVR)的影响
机译:HCV / HIV的患者在用Peginterferon Alfa-2a(Pegasys)加上利巴韦林(Copegegs)后HCV治疗后实现持续的病毒学反应,具有改善的健康相关的生活质量
机译:评估患有不同疾病类别并持续对Intron(rtm)A做出反应的成人慢性丙型肝炎患者的健康相关生活质量。
机译:Ledipasvir-Sofosbuvir组合在丙型肝炎病毒感染患者和持续病毒学应答相关因素中的有效性
机译:Ledipasvir-Sofosbuvir组合在丙型肝炎病毒感染患者和持续病毒学应答相关因素中的有效性